Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.84 SEK | +6.18% | +5.80% | -43.85% |
Apr. 26 | Nanologica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 11 | Nanologica's New COO to Take Office in May | MT |
Sales 2024 * | 89.3M 8.17M | Sales 2025 * | 181M 16.58M | Capitalization | 243M 22.26M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 2.5 x |
Net cash position 2024 * | 19.6M 1.79M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.34 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.86% |
1 day | +5.45% | ||
1 week | +5.07% | ||
Current month | -14.20% | ||
1 month | -13.17% | ||
3 months | -40.70% | ||
6 months | -44.50% | ||
Current year | -44.23% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Bhagwani
CEO | Chief Executive Officer | 49 | 10-12-31 |
Eva Osterman
DFI | Director of Finance/CFO | 53 | 16-12-31 |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 66 | 11-12-31 | |
Director/Board Member | 64 | 20-12-31 | |
Anders Rabbe
BRD | Director/Board Member | 54 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 5.84 | +6.18% | 23 900 |
24-04-26 | 5.5 | -1.43% | 483,112 |
24-04-25 | 5.58 | +0.72% | 31,352 |
24-04-24 | 5.54 | -2.12% | 26,594 |
24-04-23 | 5.66 | +2.54% | 49,009 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 09:39 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-44.23% | 22.19M | |
+4.39% | 40.29B | |
-25.15% | 20.6B | |
-14.52% | 13.21B | |
-10.29% | 9.69B | |
-13.48% | 9.66B | |
+9.07% | 6.61B | |
+3.01% | 6.42B | |
-30.31% | 5.29B | |
-21.00% | 3.3B |
- Stock Market
- Equities
- NICA Stock